What is Critical Diagnostics?
Critical Diagnostics, operating at www.criticaldiagnostics.com, is dedicated to advancing patient care by developing innovative biomarkers that enable physicians to optimize treatment strategies for cardiovascular diseases. The company's solutions also aim to contain escalating healthcare costs. With an established global presence, Critical Diagnostics boasts distribution partners in 50 countries, effectively reaching two-thirds of the world's population and demonstrating a robust international market penetration.
How much funding has Critical Diagnostics raised?
Critical Diagnostics has raised a total of $11.1M across 2 funding rounds:
Private Equity
$2.6M
Private Equity
$8.5M
Private Equity (2012): $2.6M, investors not publicly disclosed
Private Equity (2018): $8.5M, investors not publicly disclosed
What's next for Critical Diagnostics?
The substantial enterprise-level funding, particularly the recent major strategic investment, positions Critical Diagnostics for accelerated growth and market expansion. This capital infusion is expected to fuel further research and development into their novel biomarker technology, potentially leading to new diagnostic tools and improved patient outcomes in cardiovascular care. The company's extensive global distribution network suggests a strategic focus on scaling operations and solidifying its international market share, leveraging this financing to enhance its competitive edge in the healthcare diagnostics sector.
See full Critical Diagnostics company page
